Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on PolyNovo.
RELATED STOCKHEAD STORIES
News
Last Orders: What you might have missed on the ASX today
Experts
ScoPo’s powerplays: Searching for gems as healthcare sector languishes
News
Last Orders: What you might have missed on the ASX today
Director Trades
The most noteworthy directors’ trades on the ASX in 2020
Director Trades
Directors’ Trades: Which ASX directors made the biggest buys and sales last week?
News
Last Orders: What you might have missed on the ASX today
Health & Biotech
Check up: Maybe next week will be better?
Health & Biotech
We’re still here: investors keen on health despite market shun
Health & Biotech
Scale-up secret sauce: These are the ingredients for medtech growth
Director Trades
Directors Trades: This anti-snoring device maker needed capital to survive COVID-19; one director put in $3.7m
Health & Biotech
Zelira, PolyNovo prove even a pandemic can’t stand in the way of good clinical results
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health: When don’t you want to reveal a $1.3m deal? When it’s not selling COVID cures to China
News
Kick Back: The 10 biggest stories you might have missed on Stockhead this week
Health & Biotech
Dr Boreham’s Crucible: Polynovo moves onto hernia treatments after conquering burns market
News
Hindsight’s a wonderful thing — these stocks could’ve got you the best returns in the past 10 years
Health & Biotech